Assessment of myocardial viability in patients before revascularization;Valoración de la viabilidad miocárdica en pacientes prerrevascularización

Revista Espanola de Cardiologia

Volumn 56, Issue 7, 2003, Pages 721-733

  Jiménez Borreguero, Luiz Jesús ^a,b   Ruiz Salmerón, Rafael ^c  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b HOSPITAL RUBER INTERNACIONAL   (Spain)

^c HOSPITAL DO MEIXOEIRO   (Spain)

Author keywords

Echocardiography; Magnetic resonance; Myocardial infarction; Myocardial viability; Positron emission tomography; Technetium; Thallium

Indexed keywords

GADOLINIUM; TECHNETIUM; THALLIUM;

ACUTE HEART INFARCTION; CELL METABOLISM; CONTRAST ENHANCEMENT; CORONARY ARTERY RECANALIZATION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE NECROSIS; HEART SCINTISCANNING; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; HUMAN; HYPOTHESIS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PUBLICATION; REVIEW; STANDARD; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 17544395921     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13049654     Document Type: Review

References (90)

1. Chatterjee K, Swan HJ, Parmley WW, Sustaita H, Marcus HS, Matloff J. Influence of direct myocardial revascularization on left ventricular asynergy and function in patient with coronary heart disease with and without previous myocardial infarction. Circulation 1973;47:276-86.
2. Mahrholdt H, Wagner A, Judd RM, Sechtem U. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J 2002;23:602-19.
3. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72(Suppl 5):123-35.
4. Harris PJ, Harrell FE, Lee KL, Behar VS, Rosati RA. Survival in medically treated coronary artery disease. Circulation 1979;60:1259-69.
5. Hammermeister KE, De Rouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 1979;59:421-30.
6. Mock MB, Ringqvist I, Fisher LD. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 1982:66:562-8.
7. Elefteriades JA, Tolis G Jr, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993;22:1411-7.
8. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-95.
9. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997;96:793-800.
10. Al-Mohammad C, Mahy IR, Norton MY, Hillis G, Patel JC, Mikecz P, et al. Prevalence of hibernating myocardium. in patients with severely impaired ischaemic left ventricles. Heart 1998;80:559-64.
11. Redwood SR, Ferrari R, Marber MS. Myocardial hibernation and stunning: From physiological principles to clinical practice. Heart 1998;80:218-22.
12. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
13. Nixon JV, Brown CN, Smitherman TC. Identification of transient and persistent segmental wall motion abnormalities in patients with unstable angina by two-dimensional echocardiography. Circulation 1982;65:1497-503.
14. Kloner RA, Allen J, Cox TA, Zheng Y, Ruiz CE. Stunned left ventricular myocardium after exercise treadmill testing in coronary artery disease. Am J Cardiol 1991;68:329-34.
15. Vanoverschelde LJ, Wijns W, Depre C, Essamri B, Heyndrickx G, Borgers M, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral dependent myocardium. Circulation 1993;87:1513-23.
16. Marinho NVS, Keogh BE, Costa DC, Ell PJ, Lammertsma AA, Eli PJ, et al. Pathophysiology of chronic left ventricular dysfunction: New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996;93:737-44.
17. Ito BR. Gradual onset of myocardial ischemia results in reduced myocardial infarction. Association with reduced contractile function and metabolic downregulation. Circulation 1995;91:2058-70.
18. St Louis JD, Hughes GC, Kypson AP, DeGrado TR, Donovan CL, Coleman RE, et al. An experimental model of chronic myocardial hibernation. Ann Thorac Surg 2000;69:1351-7.
19. Mari C, Strauss WH. Detection and characterization of hibernating myocardium. Nucl Med Commun 2002;23:311-22.
20. Schulz R, Heusch G. Hibernating myocardium. Heart 2000;84:587-94.
21. Elsässer A, Schlepper M, Klövekorn WP, Cai WJ, Zimmermann R, Müller KD, et al. Hibernating myocardium, an incomplete adaptation to ischemia. Circulation 1997;96:2920-31.
22. Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med 1998;339:173-81.
23. Brunken R, Tillisch J, Schwaiger M, Child JS, Marshall R, Mandelkern M, et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986;73:951-63.
24. Lewis SJ, Sawada SG, Ryan T, Segar DS, Armstrong WF, Feigenbaum H. Segmental wall motion abnormalities in the absence of clinically documented myocardial infarction: clinical significance and evidence of hibernating myocardium. Am Heart J 1991;121:1088-94.
25. Rahimtoola SH. Importance of diagnosing hibernating myocardium: How and in whom? J Am Coll Cardiol 1997;30:1701-6.
26. Iskander S, Iskandrian AE. Prognostic utility of myocardial viability assessment. Am J Cardiol 1999;83:696-702.
27. Go RT, MacIntyre WJ, Cook SA, Neumann DR, Brunken RC, Saha GB, et al. The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction. J Nucl Cardiol 1996;3:96-104.
28. Auerbach MA, Schöder H, Hoh C, Gambhir SS, Yaghoubi S, Sayre JW, et al. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 1999;99:2921-6.
29. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
30. 201T1 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-41.
31. Iskandrian AS, Hakki A, Kane SA, Goel IP, Mundth ED, Hakki A, et al. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary artery bypass grafting. Am J Cardiol 1983;51:1312-6.
32. Samady H, Elefteriades JA, Abbott BG, Mattera JA, McPherson CA, Wackers FJ. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 1999;100:1298-304.
33. DiCarli MF, Asgarzadi EF, Schelbert HR, Brunken RC, Laks H, Phelps ME, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:3436-44.
34. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
35. Castell J, Condell-Riera J, Roselló Urgell J, Fraile López-Amor M, Hornero Sos F, Aguadé Bruix S, et al (Grupo de trabajo de Cardiología Nuclear, SEC). Valoración de la viabilidad miocárdica mediante tecnecio-99m isonitrilo y talio-201. Resultados del protocolo multicéntrico español. Rev Esp Cardiol 1997;50:320-30.
36. Tamaki N, Kawamoto M, Tadamura E, Magata Y, Yonekura Y, Nohara R, et al. Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography. Circulation 1995;91:1697-705.
37. Borges-Neto S, Shaw LJ, Kesler K, Sell T, Peterson ED, Coleman RE, et al. Usefulness of serial reaionuclide angiography in predicting cardiac death after coronary artery bypass grafting and comparison with clinical and cardiac catheterization data. Am J Cardiol 1997;79:851-5.
38. Dubnow MH, Burchell HB, Titus JL. Postinfarction ventricular aneurysm: a clinicomorphologic and electrocardiographic study of 80 cases. Am Heart J 1965;70:753-60.
39. Roberts CS, Maclean D, Maroko P, Kloner RA. Early and late remodeling of the left ventricle after acute myocardial infarction. Am J Cardiol 1984;54:407-10.
40. La Canna GL, Rahimtoola SH, Visioli O, Giubbini R, Alfieri O, Zognio M, et al. Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J 2000;21:1358-67.
41. Cwajg JM, Cwajg E, Nagueh SF, Copelen HA, Qureshi U, Quinones MA, et al. Assessment of myocardial viability using 2D echo measurement of end-diastolic wall thickness: relation to Tl-201 uptake and comparative prediction of recovery of function. Circulation 1998;98(Suppl):1-153.
42. Furukawa T, Haque T, Takahashi M, Kinoshita M. An assessment of dobutamine echocardiography and end-diastolic wall thickness for predicting post-revascularization functional recovery in patients with chronic coronary artery disease. Eur Heart J 1997;18:798-806.
43. Perrone-Filardi P, Bacharach SL, Dilsizian V, Maurea S, Marin-Neto JA, Arrighi JA, et al. Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischaemic left ventricular dysfunction. J Am Coll Cardiol 1992;20:161-8.
44. Cho S, McConnell MV. Echocardiographic and magnetic resonance methods for diagnosing hibernating myocardium. Nucl Med Commun 2002;23:331-9.
45. Baer FM, Theissen P, Schneider CA, Voth E, Sechtem U, Schicha H, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998;31:1040-8.
46. Hoffer EP, Dewe W, Celentano C, Pierard LA. Low-level exercise echocardiography detects contractile reserve and predicts reversible dysfunction after acute myocardial infarction: comparison with low-dose dobutamine echocardiography. J Am Coll Cardiol 1999;34:989-97.
47. Lu C, Carlino M, Fragasso G, Maisano F, Margonato A, Cappelletti A, et al. Enoximone echocardiography for predicting recovery of left ventricular dysfunction after revascularization: a novel test for detecting myocardial viability. Circulation 2000;101:1255-60.
48. Hansen TH, Segar DS. The use of dobutamine stress echocardiography for the determination of myocardial viability. Clin Cardiol 1996;19:607-12.
49. Pierard LA, Hoffer EP. Role of stress echocardiography in heart failure. Am J Cardiol 1998;81:G111-4.
50. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
51. Sawada S. Dobutamine echocardiography for detection of viable myocardium in ischemic cardiomyopathy. Echocardiography 2000;27:69-77.
52. Feigenbaum H. Coronary artery disease: detection of ischemic muscle. En: Feigenbaum H, editor. Echocardiography. Baltimore: Williams & Wilkins, 1994; p. 447-65.
53. Kornbluth M, Liang DH, Brown P, Gessford E, Schnittger I. Contrast echocardiography is superior to tissue harmonics for assessment of left ventricular function in mechanically ventilated patients. Am Heart J 2000;140:291-6.
54. Kornbluth M, Liang DH, Paloma A, Schnittger I. Native tissue harmonic imaging improves endocardial border definition and visualization of cardiac structures. J Am Soc Echocardiogr 1998;11:693-701.
55. Baer FM, Theissen P, Crnac J, Schmidt M, Deutsch HJ, Sechtem U, et al. Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J 2000;21:981-91.
56. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-60.
57. Ruiz-Salmerón RJ, Ponce de León E, López A, Romeo D, Del Campo V, Nanadayapa R, et al. Capacidad del protocolo de gated-SPECT reposo/dobutamina para predecir la recuperación contráctil posrevascularización de áreas miocárdicas disinérgicas. Rev Esp Cardiol 2000;53:1052-62.
58. Jiménez Borreguero LJ, Tejero Romero C, Chillón Terrón M, Sánchez Bustos A. Perfusión miocárdica mediante resonancia magnética sin estrés. Resultados preliminares [abstract]. Rev Esp Cardiol 2001;54(Supl 2):333.
59. Rogers WJ, Kramer CM, Geskin G, Hu YL, Theobald TM, Vido DA, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 1999;99:744-50.
60. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-72.
61. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083-9.
62. Ito H, Iwakura K, Oh H, Masuyama T, Hori M, Higashino Y, et al. Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability. Circulation 1995;91:656-62.
63. Brochet E, Czitrom D, Karila-Cohen D, Seknadji P, Faraggi M, Benamer H, et al. Early changes in myocardial perfusion patterns after myocardial infarction: relation with contractile reserve and functional recovery. J Am Coll Cardiol 1998;32:2011-7.
64. Swinburn JM, Lahiri A, Senior R. Intravenous myocardial contrast echocardiography predicts recovery of dysynergic myocardium early after acute myocardial infarction. J Am Coll Cardiol 2001;38:19-25.
65. Zoghbi WA. Evaluation of myocardial viability with contrast echocardiography. Am J Cardiol 2002;90(Suppl 10A):J65J-71.
66. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
67. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36:1985-991.
68. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd R. Transmural extent of acute myocardial infarction predicts long-term Improvement in contractile function. Circulation 2001;104:1101-7.
69. Gerber BL, Rochitte CE, Bluemke DA, Melin JA, Crosille P, Becker LC, et al. Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction. Circulation 2001;104:998-1004.
70. Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002;106:2322-7.
71. Hillernbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000;102:1678-83.
72. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-9.
73. Klein C, Nekolla, SG, Bengel FM, Momose M, Sammer A, Haas F, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-7.
74. Candell-Riera J, Aguadé S, Castell J, Cortadellas J. Isonitrilos marcados con tecnecio-99m frente al talio-201 en la enfermedad coronaria. Rev Esp Cardiol 1994;47(Supl 4):101-15.
75. Pohost GM, Alpert NM, Ingwall JS, Strauss HW. Thallium redistribution: mechanism and clinical utility. Semin Nucl Med 1980;10:70-93.
76. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-6.
77. Dilsizian V, Perrone-Filardi P, Arríghi JA, Bacharach SL, Quyyumi AA, Freedman NM, et al. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium: comparison with metabolic activity by positron emission tomography. Circulation 1993;88:941-52.
78. Bonow RO. Identification of viable myocardium. Circulation 1996;94:2674-80.
79. Dakik HA, Howell JF, Lawrie GM, Espada R, Weilbaecher DG, He Z-X, et al. Assessment of myocardial viability with 99mTc-Sestamibi tomography before coronary bypass graft surgery. Correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997;96:2892-8.
80. Maes AF, Borges M, Flameng W, Van de Werf F, Ausma JJ, Sergeant P, et al. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m Sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol 1997;29:62-8.
81. Tamaki N. Current status of viability assessment with positron tomography. J Nucl Cardiol 1994;1:40-7.
82. Udelson JE. Steps forward in the assessment of myocardial viability in left ventricular dysfunction. Circulation 1998;97:833-8.
83. Yabe T, Mitsunami K, Inubushi T, Kinoshita M. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by phosphorus-31 magnetic resonance spectroscopy. Circulation 1995;92:15-23.
84. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2002;39:1159-62.
85. Sadanandan S, Buller C, Menon V, Dzavik V, Terrin M, Thompson B, et al. The late open artery hypothesis. A decade later. Am Heart J 2001;142:411-21.
86. Williams DO, Braunwald E, Knatterud G, Babb J, Bresnahan J, Greenberg MA, et al. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. Circulation 1992;85:533-42.
87. Dzavik V, Beanlands DS, Davies RF, Leddy D, Marquis JF, Teo KK, et al. Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]- A pilot study). Am J Cardiol 1994;73:856-61.
88. Topol EJ, Califf RM, Vandormael M, Grines CL, George BS, Sanz ML, et al. A randomized trial of late reperfusion therapy for acute myocardial infarction: Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. Circulation 1992;85:2090-9.
89. Horie H, Takahashi M, Minai K, Izumi M, Takaoka A, Nozawa M, et al. Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty. Circulation 1998;98:2377-82.
90. Yousef ZR, Redwood SR, Bucknall CA, Sulke AN, Marber MS. Latue intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study). J Am Coll Cardiol 2002;40:869-76.